« previous next »
Pages: [1]

Author Topic: (Abst.) Safety and efficacy of drugs for MS fatigue  (Read 35 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9843
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Safety and efficacy of drugs for MS fatigue
« on: December 19, 2020, 07:46:45 pm »

This study in The Lancet Neurology (November 23, 2020) finds that several drugs commonly prescribed for MS fatigue are no more effective than placebo "and caused more frequent adverse events." The article is entitled "Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: A randomised, placebo-controlled, crossover, double-blind trial":


https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(20)30354-9/fulltext
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
2 Replies
237 Views 		Last post September 08, 2019, 04:17:59 pm
by agate
0 Replies
132 Views 		Last post September 30, 2018, 07:31:15 pm
by agate
0 Replies
62 Views 		Last post December 14, 2019, 04:59:16 pm
by agate
0 Replies
37 Views 		Last post December 02, 2020, 03:37:34 pm
by agate
0 Replies
68 Views 		Last post January 01, 2021, 03:26:12 pm
by agate